Detalhe da pesquisa
1.
Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study.
Int J Infect Dis
; 123: 97-103, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987472